 |
NewsSelect the archived year you would like to view: Duragesic® and Fentanyl Patches RecalledFebruary 21, 2008Update: August 12, 2008 Watson Phamaceuticals, Inc., issued a voluntary recall of one lot of 75 mcg/hr Fentanyl transdermal system CII patches. Lot 92461850, expiration date 8/31/2009, sold in the United States from January 30 - March 19, 2008 was recalled due to a small number of the patches found to be leaking. Update: March 3, 2008 Actavis Inc., notified health care professionals of a voluntary recall of all lots of Fentanyl transdermal system CII patches sold in the United States. Actavis Inc. announced a nationwide recall of certain lots of Fentanyl transdermal system CII Patches sold in the United States and labeled with an Abrika or Actavis label. The product may have a fold-over defect which can cause the patch to leak and expose patients or caregivers directly to the fentanyl gel. Exposure to fentanyl gel may lead to serious adverse events, including respiratory depression and possible overdose, which may be fatal. The lots covered by this recall include doses of 25, 50, 75, and 100 mcg/hr and are listed in the firm's press release. See the complete MedWatch 2008 safety summary, including a link to the firm's press release, at: Related News:
|